Nurix Therapeutics (NRIX) announced that the U.S. Food and Drug Administration, FDA, has cleared the IND for the IRAK4 degrader ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and ...

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 GS-6791/NX-0479 has potential clinical ...

Autoimmunity results from complex disruptions in immune signaling pathways where genetic predisposition and environmental factors trigger the activation of self-reactive lymphocytes, excessive ...

Background Muscle wasting and weakness (sarcopenia) are commonly associated with COPD causing frailty and reduced quality of ...

Orthodontic treatments often take years, but a breakthrough discovery could drastically shorten this period. Researchers have uncovered that ATF6, a ...

Apogee's strong financial position, with $731.1 million in cash, funds operations through Q1 2028, de-risking its ambitious ...

A regimen based on Roche's CD20xCD3 bispecific antibody Columvi has been approved in the EU as a second-line therapy for ...

Researchers in South Korea have found that an extract made from in vitro-grown cannabis callus tissue may be a valuable new ...

Cytokines play a crucial role in connecting the immune system with the brain, affecting mood and behavior through ...

A study identifies a brain pathway linking inflammation to dopamine loss and apathy in cancer. Researchers found that IL-6 ...

The RAINIER Study (NCT06496607) is an ongoing Phase IIa clinical trial investigating Solrikitug for adults with asthma. This randomized, double-blind, placebo-controlled study evaluates three dose ...